PYRIMIDINE-2,4,6-TRIONES FOR USE IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
申请人:Cambria Pharmaceuticals, Inc.
公开号:EP3144299A1
公开(公告)日:2017-03-22
The present invention relates to the identification of inventive pyrimidine-2,4,6- triones (PYT compounds) of formula (I) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the inventive PYT compounds.
本发明涉及式(I)的发明性嘧啶-2,4,6-三酮(PYT化合物)及其药物组合物的鉴定,用于治疗肌萎缩性脊髓侧索硬化症(ALS)和其他神经退行性疾病。本发明还提供了制备本发明PYT化合物的方法。